Inpharmatica Licenses Biopendium™ to Schering
News Oct 18, 2005
Inpharmatica Ltd has announced that scientists from Schering AG, Germany and Inpharmatica Ltd will collaborate in the area of protein structures with the aim to prioritise proteins as drug targets.
Inpharmatica will make its Biopendium™ as well as Chematica™ technologies available to Schering.
The objective is to develop techniques and approaches which will support Schering AG's project prioritisation activities.
This is the second such contract won by Inpharmatica and follows an agreement signed with Pfizer in January 2005 to assess druggability of a range of nominated proteins.
Biopendium provides comprehensive sequence annotation for over 150 organisms, making it the world's pre-eminent pre-computed, annotation database.
Superior annotation is generated by moving beyond traditional text-based data to a system that incorporates pharmaceutically relevant, protein 3D structure and ligand information.
Chematica and Biopendium are integral components of Inpharmatica's gene-to-candidate technology platform which integrates biology- and chemistry-based drug discovery activities.
Inpharmatica's technologies optimise target selection based on druggability, and enable rapid identification of hits and selection of high quality leads and pre-clinical candidates, which are prioritised on the basis of good drug-like characteristics and clinical indication.
Commenting on the announcement, John Lisle, CEO of Inpharmatica, said, “Target druggability assessment is essential for efficient drug development.”
“Inpharmatica has made a significant investment in this area in recent years culminating in our first collaboration in the area earlier this year.”
“We now look forward to this opportunity to collaborate with Schering AG in this exciting area, creating a valuable support to drug discovery decision making.”
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE